UCP2 and type 2 diabetes mellitus: The possibility that UCP2 might be a relevant GSIS regulator has provoked considerable interest (see, e.g., [5,25–27] for reviews) as this mitochondrial carrier could well be an attractive therapeutic target in the treatment of type 2 diabetes.